交易 Compass Therapeutics, Inc. - CMPX 差價合約

交易條件

• 類型: 差價合約
• 點差: 0.05
• 長倉隔夜倉息調整: -0.02226%
• 短倉隔夜倉息調整: 0.00004%
• 隔夜倉息調整時間: 22:00 (UTC)
• 貨幣: USD
• 最低成交量: 1
• 保證金: 50.00%
• 證券交易所: United States of America
• 交易佣金: 0%
• 保證止損溢價: 1%

主要統計數據

• 前收盤價: 5.23
• 開倉: 5.2
• 1 年變化: 181.08%
• 日區間: 5.19 - 5.4

Compass Therapeutics Inc. (NASDAQ: CMPX) is a clinical-stage biotechnology company developing next-generation antibody therapeutics for cancer and autoimmune diseases. Its pipeline includes immune checkpoint inhibitors and T-cell engagers with enhanced potency and selectivity. Compass emphasizes modular design and multispecific formats to overcome limitations of current biologics. It provides investors early exposure to high-potential oncology innovation and differentiated biologic platforms.